Analyst firms · Oppenheimer · LOW
Oppenheimer LOW price target and rating history
Lowe's Companies Inc. (LOW) · Consumer Discretionary
Oppenheimer rates Lowe's Companies Inc. (LOW) Outperform with a $305 price target, as of its latest action on Sep 24, 2024. It has published 3 rating actions on LOW since December 2021, including 1 upgrade and 1 downgrade. Across 5 firms with a LOW price target in the last 12 months, the median target is $280.
- Current rating
- Outperform
- Price target
- $305
- Median target, all firms
- $280
- Actions on LOW
- 3
Oppenheimer price target on LOW
Every Oppenheimer rating on LOW
- Sep 24, 2024
- Jan 22, 2024
- Dec 6, 2021
How other firms rate LOW
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Stifel | Sell | $190 | Nov 13, 2026 |
| Gordon Haskett | Hold | $200 | Sep 24, 2026 |
| Telsey Advisory Group | Outperform | $280 | May 21, 2026 |
| Citigroup | Buy | $285 | May 12, 2026 |
| BofA Securities | Neutral | May 5, 2026 | |
| Barclays | Overweight | $285 | Jan 7, 2026 |
Questions about Oppenheimer and LOW
- What is Oppenheimer's price target for LOW?
- Oppenheimer's latest stated price target for Lowe's Companies Inc. (LOW) is $305, from its action on Sep 24, 2024.
- What is Oppenheimer's rating on LOW?
- Oppenheimer rates LOW Outperform, a bullish rating, as of Sep 24, 2024.
- When did Oppenheimer last change its view on LOW?
- On Sep 24, 2024, Oppenheimer upgrades to Outperform from Perform, price target $230 to $305.
- How does Oppenheimer's LOW target compare with other analysts?
- Across 5 firms with a LOW price target in the last 12 months, the median target is $280.
More LOW rating histories
- Stifel3
- Gordon Haskett4
- Telsey Advisory Group12
- Citigroup3
- Barclays3
- Bernstein3
- Loop Capital3
- Evercore ISI4
- Truist Securities3
- Wedbush4
- Jefferies3
- Morgan Stanley5
All Oppenheimer ratingsLOW news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.